CDK9: From basal transcription to cancer and AIDS

Cancer Biology and Therapy

Volumn 1, Issue 4, 2002, Pages 342-347

  De Falco, Giulia ^a,b   Giordano, Antonio ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b Temple University   (United States)

Author keywords

Cdk9; Cell cycle; Cyclin T; HIV; Transcription

Indexed keywords

CDK9 PROTEIN, HUMAN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 9; DROSOPHILA PROTEIN; TAF6 PROTEIN, DROSOPHILA; TATA BINDING PROTEIN ASSOCIATED FACTOR; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR II; TRANSCRIPTION FACTOR IID; TRANSCRIPTION FACTOR IIH;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; APOPTOSIS; CELL DIFFERENTIATION; DROSOPHILA; GENE LIBRARY; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NEOPLASM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REVIEW; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE 9; CYCLIN-DEPENDENT KINASES; DNA, COMPLEMENTARY; DROSOPHILA; DROSOPHILA PROTEINS; GENE LIBRARY; GENE PRODUCTS, TAT; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TRANSCRIPTION FACTOR TFIID; TRANSCRIPTION FACTOR TFIIH; TRANSCRIPTION FACTORS, TFII; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 1842832323     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.1.4.6113     Document Type: Review

References (80)

1. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994; 266:1821-8.
2. Nurse P, Bisset Y. Gene required in G1 for commitment to cell cycle and in G2 for control of mitosis in fission yeast. Nature 1991; 292:558-60.
3. Reed SI, Wittenberg C. Mitotic role for the Cdc28 protein kinase of Saccaromyces cerevisiae. Proc Nat Acad Sci USA 1990; 87:5697-701
4. Draetta G. Cell cycle control in eukaryotes: molecular mechanism of cdc2 activation. Trends Biochem Sci 1990; 15:378-80.
5. Forsburg SL, Nurse P. Cell cycle regulation in the yeast Saccaromyces cerevisiae and saccaromyces pombe. Annu Rev Cell Biol 1991; 7:227-56.
6. Pines J, Hunter T. p34cdc2: the S and M kinase? New Biol 1990; 2:389-401.
7. Hunter T, Pines J. Cyclins and cancer. II: Cyclin D and Cdk inhibitors come of age. Cell 1994; 79:573-82.
8. Sherr CJ: G1 phase progression: cycling on cue. Cell 1994; 79:551-5.
9. Grana X, De Luca A, Sang N, Fu Y, Claudio PP, Rosenblatt J, et al. PITALRE, a novel cdc2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc Nat Acad Sci USA 1994; 91:3834-38. (Pubitemid 24139526)
10. Lapidot LY, Patinkin D, Prody CA, Ehrlich G, Seidman S, Ben AR, et al. Cloning and antisense oligodeoxynucleotides inhibition of a human homolog of cdc2 required in hematopoiesis. Proc Nat Acad Sci USA 1992; 89:579-83.
11. Hanks SK, Quinn AM, Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domain. Science 1988; 241:42-52.
12. Bullrich F, MacLachlan T, Sang N, Druck T, Veronese ML, Allen S, et al. Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, Cdk6, PISSLRE and PITALRE, and a Cdk inhibitor, p27kip1, to regions involved in human cancer. Cancer Research 1995; 55:1199-205.
13. Offit K, Parza NZ, Jhanwar SC, Filippa D, Wachtel M, Chagenti RS. Clusters of chromosome 9 aberrations are associated with clinico-pathologic subsets of non-Hodgkin's lymphoma. Genes Chromosomes Cancer 1993; 7:1-7. (Pubitemid 23141734)
14. Orlow I, Lianes P, Lacombe L, Dalbagni G, Reuter VE, Cordon-Cardo C. Chromosome 9 allelic losses ad microsatellite alterations in human bladder tumors. Cancer Res1994; 54:2848-51.
15. Peng J, Zhu Y, Milton JT, Price DH. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev 1998; 12:755-62. (Pubitemid 28134306)
16. De Luca A, Russo P, Severino A, Baldi A, Battista T, Cavallotti I, et al. Pattern of expression of Cyclin T1 in human tissues. J of Histochem Cytochem 2001; 49:685-92. (Pubitemid 32553439)
17. Herrmann CH, Carroll RG, Wei P, Jones KA, Rice AP. Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines. J Virol 1998; 72:9881-8. (Pubitemid 28520854)
18. Fujinaga K, Taube R, Wimmer J, Cujec TP, Peterlin BM. Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc Natl Acad Sci USA 1999; 96:1285-90.
19. Fu TJ, Peng J, Lee Ga, Price DH, Flores O. Cyclin K functions as a Cdk9 regulatory subunit and participates in RNA Polymerase II transcription. J Biol Chem 1999; 274:34527-30. (Pubitemid 129509485)
20. Zhu Y, Pe'hery T, Peng J, Ramanathan Y, Marshall N, Amendt B, et al. Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes Dev 1997; 11:2622-32.
21. Marshall NF, Peng J, Xie P, Price DH. Control of RNA Polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J Biol Chem 1996; 271,27176-83. (Pubitemid 26359140)
22. Zhou Q, Chen D, Pierstorff E, Luo K. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J 1998; 17:3681-91. (Pubitemid 28327386)
23. O'Keeffe B, Fong Y, Chen D, Zhou S, Zhou Q. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated Tat stimulation of HIV-1 transcription. J Biol Chem 2000; 275:279-87. (Pubitemid 30038983)
24. Wei P, Garber ME, Fang SM, Fisher WH, Jones KA. A novel Cdk9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998; 92:451-62. (Pubitemid 28101109)
25. Bukau B, Horwich AL. The Hsp70 and Hsp60 chaperone machines. Cell 1998; 92:351-66. (Pubitemid 28093013)
26. Gerber MR, Farrell A, Deshaies RJ, Herskowitz I, Morgan DO. Cdc37 is required for association of the protein kinase Cdc28 with G, and mytotic cyclins. Proc Natl Acad Sci USA 1995; 92:4651-5.
27. Grammatikakis M, Lin J, Grammatikakis A, Tsichlis PN, Cochran BH. p50 (cdc37) acting in concert with Hsp90 is required for Raf-1 function. Mol Cell Biol 1999; 19:1661-72. (Pubitemid 29098225)
28. Lamphere L, Fiore F, Xu X, Brizuela L, Keezer S, Sardet C, et al. Interaction between Cdc37 and Cdk4 in human cells. Oncogene 1997; 14:1999-2004. (Pubitemid 27217814)
29. Stepanova L, Leng X, Parker SB, Harper JW. Mammalian p50 cdc37 is a protein-kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes Dev 1996; 10:1491-502. (Pubitemid 26260706)
30. Hirose Y, Manley JL. RNA polymerase II is an essential mRNA polyadenilation factor. Nature 1998; 395:93-6. (Pubitemid 28420237)
31. McCracken S, Fong N, Yankulov K, Ballantyne S, Pan G, Greenblatt J, et al. The C-Terminal Domain of RNA Polymerase II couples mRNA processing to transcription. Nature 1997; 385:357-61.
32. Mortillaro MJ, Blencowe BJ, Wei X, Nakayasu H, Du L, Warren SD, et al. A hyperphos-phorylated form of the large subunit of RNA Polymerase II is associated with splicing complexes and the nuclaer matrix. Proc Natl Acad Sci USA 1996; 93:8253-7. (Pubitemid 26269543)
33. Dahmus ME. Reversible phosphorylation of the C-terminal domai of RNA Polymerase II. J Biol Chem 1996; 217:19009-12. (Pubitemid 26271553)
34. O'Brien T, Hardin S, Greenleaf A, Lis JT. Phosphorylation of RNA Polymerase II C-Terminal domain and transcriptional elongation. Nature 1994; 370:75-7. (Pubitemid 24216957)
35. Dahmus ME. Phosphorylation of mammalian RNA Polymerase II. Methods Enzymol 1996; 273:185-93. (Pubitemid 26317698)
36. Dingwall C, Ernberg I, Gait MJ, Green SM, Heaphy S, Karn J, et al. Human immunodeficiency virus 1 Tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci USA 1989; 86:6925-9. (Pubitemid 19240844)
37. Weeks KM, Ampe MC, Schultz S, Steitz T, Crothers DM. Fragments of the HIV-1 Tat protein specifically bind TAR RNA. Science 1990; 249:1281-5.
38. Jones KA, Peterlin BM. Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem 1994; 63:717-43. (Pubitemid 24218647)
39. Cujec TP, Cho H, Maldonado E, Mejer J, Reinberg D, Peterlin BM. The human immunodeficiency virus transactivator Tat interacts with the RNA Polymerase II holoenzyme. Mol Cell Biol 1997; 17:1817-23. (Pubitemid 27133266)
40. Kashanki F, Pira G, Radonovich MF, Duval JF, Fattaey A, Chian CM, et al. Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature 1994; 367:295-299.
41. Herrmann CH, Rice AP. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA Polymerase II: candidate for a Tat cofactor J Virol 1995; 68:1612-20.
42. Yang X, Herrmann CH, Rice AP. The human immunodeficiency virus Tat proteins specifically associates with TAK in vivo and require the carboxyl-terminal domain of RNA Polymerase II for function. J Virol 1996; 70:4576-84.
43. Marshall NF, Price DH. Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J Biol Chem 1995; 270:12335-8.
44. Liu Y, Wang Z, Rana TM. Visualizing a specific contact in the HIV-1 Tat protein fragment and transactivation responsive region TAR complex by photocrosslinking. J Biol Chem 1997; 271:10391-6. (Pubitemid 26131605)
45. Tao J, Chen L, Frankel A. Dissection of the proposed base triple in human immunodeficiency virus TAR RNA indicates the importance of the Hoogsteen interaction. Biochemistry 1997; 36:3491-5. (Pubitemid 27143501)
46. Hart CE, Ou CY, Galfin JC, Moore J, Bacheler RT Wasmuth JJ, et al. Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. Science 1989; 246:488-91. (Pubitemid 19273937)
47. Newstein M, Stanbridge EJ, Casey G, Shank PR. Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat-mediated transactivation in rodent cells. J Virol 1990; 64:4565-7. (Pubitemid 20279872)
48. Garber ME, Mayall TP, Suess EM, Meisenhelder J, Thompson NE, Jones KA. Cdk9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 Tat-P-TEFb complex to TAR RNA. Mol Cell Biol 2000; 20:6958-69.
49. Zhou M, Halanski MA, Radonovich MF, Kashanki F, Peng J, Price DH, Brady JN. Tat modifies the activity of Cdk9 to phosphorylate serine 5 of the RNA Polymerase II Carboxyl-Terminal Domain during human immunodeficiency virus type 1 transcription. Mol Cell Biol 2000; 20:5077-86. (Pubitemid 30431561)
50. Isel C, Karn J. Direct evidence that HIV-1 Tat stimulates RNA Polymerase II Carboxyl-terminal domain hyper-phosphorylation during transcriptional elongation. J Mol Biol. 1999; 290:929-41. (Pubitemid 29371730)
51. Parada C, Roeder RG. Enhanced processivity of RNA Polymerase II triggered by Tat-induced phosphorylation of its carboxyl-terminal domain. Nature 1996; 384:375-8. (Pubitemid 26408522)
52. Garcia-Martinez LF, Mavankal G, Neveu J, Lane W, Sigman D, Ivanov D, et al. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J 1997; 16:2836-50. (Pubitemid 27226220)
53. Cujec TP, Okamoto H, Fujinaga K, Meyer J, Chamberlin H, Morgan DO, et al. The HIV transactivator Tat binds to the Cdk-activating kinase and activates the phosphorylation of the carboxyl-terminal domain of RNA Polymerse II: Genes Dev 1997; 11:2645-57.
54. Drapkin R, Reinberg D. The multifunctional TFIIH complex ad transcriptional control. Trends Biochem Sci 1994; 19:504-8. (Pubitemid 24342766)
55. Joeijmakers JH, Egly JM, Vermeulen W. TFIIH: a key component in multiple DNA transactions. Curr Opin Genet Dev 1996; 6:26-33. (Pubitemid 26059047)
56. Maldonado E, Reinberg D. News on initiation and elongation of transcription by RNA Polymerase II. Curr Opin Cell Biol 1995; 7:352-61.
57. Feaver WJ, Svejstrup JQ, Henry NL, Kornberg RD. Relationship of CDK-activating kinase and RNA Polymerase II CTD kinase TFIIH/TFIIK. Cell 1994; 79:1103-9.
58. Roy R, Adamczewski JP, Seroz T, Vermeulen W, Tassan JP, Schaeffer L, Nigg EA, Joeijmakers JH, Egly JM. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell 1994; 79:1093-101.
59. Serizawa H., Makela T.P., Conaway J.W., Conaway R.C., Weinberg R.A. and Young R.A.: Association of Cdk-activating kinase subunits with transcription factor TFIIH. Nature, 374, 280-282 (1995).
60. Shiekhattar R, Mermelstein F, Fisher P, Drapkin R, Dynlacht B, Wessling HC, et al. Cdk-activating kinase complex is a component of human transcription factor TFIIH. Nature 1995; 374:283-7.
61. Harper JW, Elledge SJ. The role of Cdk7 in CAK function, a retro-retrospective. Genes Dev 1998; 12:285-9. (Pubitemid 28084258)
62. Morgan DO. Principles of Cdk regulation. Nature 1995; 374:131-4.
63. Morgan DO, Fisher RP, Espinoza FH, Farrell A, Nourse H, Chamberlin H, et al. Control of eukaryotic cell cycle progression by phosphorylation of cyclin-dependent kinases. Cancer J Sci Am 1998; 4(Suppl1):S77-83.
64. Poon RY, Yamashita K, Howell M, Ershler MA, Belyavsky A, Hunt T, et al. Cell cycle regulation of the p34cdc2/p33cdk2-activating kinase p40MO15. J Cell Sci 107:2789-99.
65. Tassan JP, Schultz SJ, Bartek J, Nigg EA. Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J Cell Biol 1994; 127:467-78. (Pubitemid 24313734)
66. Rossignol M, Kolb-Cheynel I, Egly JM. Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH. Embo J 1997; 16:1628-37. (Pubitemid 27151958)
67. Yankulov KY, Bentley DL. Regulation of Cdk7 substrate specificity by MAT 1 and TFIIH. Embo J 1997; 16:1638-46. (Pubitemid 27151959)
68. Zawel L, Kumar KP, Reinberg D. Recycling of the general transcription factors during RNA Polymerase II transcription. Genes Dev 1995; 9:1479-90.
69. Braddock M, Thorburn AM, Kingsman AJ, Kingsman SM. Blocking of Tat-dependent HIV-1 RNA modification by an inhibitor of RNA Polymerase II processivity. Nature 1991; 350:439-41. (Pubitemid 21912250)
70. Lis JT, Mason P, Peng J, Price DH, Werner J. P-TEFb kinase recruitment and function in heat shock loci. Genes Dev 2000; 14:792-803. (Pubitemid 30214999)
71. Kanazawa S, Okamoto T, Peterlin BM. Tat competes with CHTA for the binding of P-TEFb and blocks the expression of MHC II class genes in HIV infection. Immunity 2000; 12:61-70. (Pubitemid 30069215)
72. Simone C, Stiegler P, Bagella L, Pucci B, Bellan C, De Falco G, et al. Activation of MyoD-dependent transcription by cdk9/cyclin T2. Oncogene 2002; 21:4137-48. (Pubitemid 34712881)
73. Herrmann CH, Carroll RG, Wei P, Jones KA, Rice AP. Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines. J Virol 1998; 72:9881-8. (Pubitemid 28520854)
74. Burger CM, Wick M, Nuller R. Lineage-specific regulation of cell cycle gene expression in differentiating myeloid cells. J Cell Sci 1994; 107:2047-54. (Pubitemid 24226453)
75. Gao GY, Zelenska PS. Cyclins, cyclin-dependent kinases and differentiation. Bioessays 1998; 19:307-15.
76. De Falco G, Giordano A, Leoncini L. Cdk9 expression is enhanced during neural differentiation induced upon retinoic acid stimulation, in SH-SY5Y cells. (Submitted).
77. Foskett SM, Ghose R, Tang DN, Lewis DE, Rice AP. Antiapoptotic function of Cdk9 (TAK/P-TEFb) in U937 promonocytic cells. J Virol 2001; 75:1220-28. (Pubitemid 32094681)
78. De Falco G, Bagella L, Claudio PP, De Luca A, Fu Y, Calabretta B, et al.Physical interaction between Cdk9 and B-Myb results in suppression of B-Myb gene autoregulation. Oncogene 2000; 19:373-9. (Pubitemid 30077337)
79. MacLachlan TK, Sang N, Puri PL, Levrero M, Giordano A. Binding of Cdk9 to TRAF2. J of Cell Biochem 1998; 71:467-78. (Pubitemid 28521002)
80. De Falco G, Neri LM, Yu Z, De Luca A, De Falco M, Bellan C, et al. The signal transducer gp130 binds to Cdk9, a member of the cdc2-like family of kinases. Oncogene: In Press.